indigestion glp-1 nausea: How to handle GLP-1s' most common side effect GLP-1 Medicines And Gut Bacterial
Description
9 Other similar case reports prompted a retrospective analysis of endoscopy data and found a 5-fold increase in risk for residual gastric volume in those who take semaglutide even after appropriate fasting times

Clinical trials show that GLP-1 medications like semaglutide and tirzepatide can lead to a 1520% weight reduction over 1216 months, while diet and exercise typically result in 510% weight loss in the first year

Escribir por WhatsApp
The Bottom Line Whether or not you are breastfeeding, using a GLP-1 medication in the postpartum period is a personal decision that deserves careful consideration

Table 1 Adapted form: Long B, Pelletier J, Koyfman A, Bridwell RE

Do not change, adjust, or discontinue any medications without your physicians guidance
